Adv Urol

1. NISHIMURA N, Miyake M, Miyamoto T, Shimizu T, et al
   Routine Surveillance of Upper Urinary Tract Imaging for Diagnosing Upper Urinary Tract Urothelial Cancer Recurrence in Patients with Nonmuscle Invasive Bladder Cancer.
   Adv Urol. 2024;2024:5894288.
   

   >> Share

   
   

   
   Aktuelle Urol

2. HERRMANN J, Hartung FO, Kriegmair MC, Becker B, et al
   [Should we all switch to en-bloc resection of bladder tumours?].
   Aktuelle Urol. 2024;55:250-254.
   

   >> Share

   
   
3. 
   [Not Available].
   Aktuelle Urol. 2024;55:192-194.
   

   >> Share

   
   
4. 
   [Not Available].
   Aktuelle Urol. 2024;55:194.
   

   >> Share

   
   
5. 
   [Not Available].
   Aktuelle Urol. 2024;55:202-204.
   

   >> Share

   
   

   
   Anticancer Agents Med Chem

6. LI Z, Yang J, Chen L, Chen P, et al
   Moscatilin Reverses EMT Progression and its Resulting Enhanced Invasion and Migration by Affecting the TGF-beta Signaling Pathway in Bladder Cancer.
   Anticancer Agents Med Chem. 2024.
   

   >> Share

   
   

   
   AORN J

7. ROBISON M, Bush NJ
   Clamp for Safety: Improving Intravesical Chemotherapy Practices.
   AORN J. 2024;119:412-420.
   

   >> Share

   
   

   
   Appl Radiat Isot

8. KANMALAR M, Kamal R, Abdul Sani SF, Pathmanathan D, et al
   Spectroscopic diagnosis and metabolite characterization of cisplatin resistance regulated by FDFT1 in bladder cancer tissue.
   Appl Radiat Isot. 2024;210:111372.
   

   >> Share

   
   

   
   Arch Pathol Lab Med

9. RUSSELL DH, Epstein JI, Kryvenko ON, Schlumbrecht M, et al
   Adenocarcinomas of the Gynecologic Tract Involving the Urinary Bladder: A Series of 16 Cases Potentially Mimicking Urothelial Malignancy.
   Arch Pathol Lab Med. 2024;148:705-714.
   

   >> Share

   
   
10. ABDULFATAH E, Kunju LP
    Diagnostic Approach to and Differential Diagnosis of Clear Cell and Glandular Lesions of the Lower Urinary Tract.
    Arch Pathol Lab Med. 2024;148:642-648.
    

    >> Share

    
    

    
    Biochim Biophys Acta Rev Cancer

11. PICARD LC, Rich FJ, Kenwright DN, Stevens AJ, et al
    Epigenetic changes associated with Bacillus Calmette-Guerin (BCG) treatment in bladder cancer.
    Biochim Biophys Acta Rev Cancer. 2024 May 26:189123.
    

    >> Share

    
    

    
    Biomedicines

12. STOJNEV S, Conic I, Ristic Petrovic A, Petkovic I, et al
    The Association of Death Receptors and TGF-beta1 Expression in Urothelial Bladder Cancer and Their Prognostic Significance.
    Biomedicines. 2024;12:1123.
    

    >> Share

    
    

    
    Brief Bioinform

13. WU J, Zhao X, He Y, Pan B, et al
    IDMIR: identification of dysregulated miRNAs associated with disease based on a miRNA-miRNA interaction network constructed through gene expression data.
    Brief Bioinform. 2024;25:bbae258.
    

    >> Share

    
    

    
    Cancer Gene Ther

14. LIU C, Zou Z, Lu S, Jin K, et al
    CircPKN2 promotes ferroptosis in bladder cancer by promoting the ubiquitination of Stearoyl-CoA Desaturase 1.
    Cancer Gene Ther. 2024 May 27. doi: 10.1038/s41417-024-00784.
    

    >> Share

    
    

    
    Cancer Med

15. LI DX, Yu QX, Wu RC, Wang J, et al
    Efficiency of transurethral en-bloc resection vs. conventional transurethral resection for non-muscle-invasive bladder cancer: An umbrella review.
    Cancer Med. 2024;13:e7323.
    

    >> Share

    
    

    
    Cancers (Basel)

16. BLICHERT-REFSGAARD L, Graugaard-Jensen C, Norgaard M, Jensen JB, et al
    Use of Bladder-Related Medication in Non-Muscle Invasive Bladder Cancer Patients.
    Cancers (Basel). 2024;16:1936.
    

    >> Share

    
    
17. MCNALL S, Hooper K, Sullivan T, Rieger-Christ K, et al
    Treatment Modalities for Non-Muscle Invasive Bladder Cancer: An Updated Review.
    Cancers (Basel). 2024;16:1843.
    

    >> Share

    
    

    
    Cell Biochem Biophys

18. LI CC, Tsai BC, Annseles Rajula S, Hsu CH, et al
    Tannic Acid Impedes the Proliferation of Bladder Cancer Cells by Elevating Mitochondrial Pathways of Apoptosis.
    Cell Biochem Biophys. 2024 May 29. doi: 10.1007/s12013-024-01286.
    

    >> Share

    
    

    
    Cell Mol Biol (Noisy-le-grand)

19. MUSLUM O, Ahmet K, Ebru O, Ahmet T, et al
    Impacts of Chlorine 1-3 ion channels on localized bladder neoplasms.
    Cell Mol Biol (Noisy-le-grand). 2024;70:76-81.
    

    >> Share

    
    
20. YU X, Liao B, Du Z, Zhu P, et al
    EGFR/TKIs induce excessive apoptosis of bladder carcinoma cells by arresting cell cycle and promoting mitochondrial peroxidation damage.
    Cell Mol Biol (Noisy-le-grand). 2024;70:258-262.
    

    >> Share

    
    

    
    Cell Rep

21. LEE S, Bondaruk J, Wang Y, Chen H, et al
    Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis.
    Cell Rep. 2024;43:114146.
    

    >> Share

    
    

    
    Cell Signal

22. WANG X, Jin L, Zhang X, Li M, et al
    Transcriptomic profiling and risk assessment in bladder cancer: Insights from copper death-related genes.
    Cell Signal. 2024 May 27:111237. doi: 10.1016/j.cellsig.2024.111237.
    

    >> Share

    
    

    
    Chem Biol Drug Des

23. YANG Z, Guo R, Bi Y, Xu W, et al
    Peimenine unleashes therapeutic promise in urothelial bladder cancer: inhibition of proliferation, induction of cell death and modulation of key pathways.
    Chem Biol Drug Des. 2024;103:e14528.
    

    >> Share

    
    

    
    Cureus

24. AVCI MA, Arslan B, Arslan O, Ozdemir E, et al
    The Role of Thrombocyte/Lymphocyte Ratio and Aspartate Transaminase/Alanine Transaminase (De Ritis) Ratio in Prediction of Recurrence and Progression in Non-muscle Invasive Bladder Cancer.
    Cureus. 2024;16:e59299.
    

    >> Share

    
    

    
    Curr Pharm Biotechnol

25. BANSAL K, Chaudhary N, Bhati H, Vanshita, et al
    Unveiling FDA-Approved Drugs and Formulations in the Management of Bladder Cancer: A Review.
    Curr Pharm Biotechnol. 2024 May 23. doi: 10.2174/0113892010314650240514053735.
    

    >> Share

    
    

    
    EBioMedicine

26. WONG JKM, McCulloch TR, Alim L, Omer N, et al
    TGF-beta signalling limits effector function capacity of NK cell anti-tumour immunity in human bladder cancer.
    EBioMedicine. 2024;104:105176.
    

    >> Share

    
    

    
    Eur J Med Res

27. XIAO S, Chen J, Wei Y, Song W, et al
    BHLHE41 inhibits bladder cancer progression via regulation of PYCR1 stability and thus inactivating PI3K/AKT signaling pathway.
    Eur J Med Res. 2024;29:302.
    

    >> Share

    
    

    
    Eur Urol

28. BABJUK M
    Can an En Bloc Technique Improve Outcomes of Endoscopic Surgery for Non-muscle-invasive Bladder Cancer?
    Eur Urol. 2024 May 25:S0302-2838(24)02382-0. doi: 10.1016/j.eururo.2024.
    

    >> Share

    
    

    
    Front Immunol

29. YOON AR, Jiao A, Hong J, Kim B, et al
    Tumor microenvironment-modulating oncolytic adenovirus combined with GSK-3beta inhibitor enhances antitumor immune response against bladder cancer.
    Front Immunol. 2024;15:1360436.
    

    >> Share

    
    

    
    Front Med (Lausanne)

30. SAVCHENKO E, Bunimovich-Mendrazitsky S
    Investigation toward the economic feasibility of personalized medicine for healthcare service providers: the case of bladder cancer.
    Front Med (Lausanne). 2024;11:1388685.
    

    >> Share

    
    
31. BALCIK OY, Demir B, Ilhan Y, Akagunduz B, et al
    Geriatric nutritional risk index and controller nutritional status score before metastatic first-line chemotherapy predict survival in patients over 70 years of age with metastatic bladder cancer.
    Front Med (Lausanne). 2024;11:1376607.
    

    >> Share

    
    

    
    Front Oncol

32. DAVIS K, Orf J, Ballon-Landa E, Hamilton Z, et al
    Neoadjuvant chemotherapy prior to radical cystectomy for non-muscle invasive bladder cancer: national trends and pathologic outcomes.
    Front Oncol. 2024;14:1392062.
    

    >> Share

    
    
33. QIAO Y, Jia Y, Luo L, Li B, et al
    Development and validation of a nomogram to predict lymph node metastasis in patients with progressive muscle-invasive bladder cancer.
    Front Oncol. 2024;14:1342244.
    

    >> Share

    
    
34. GHALI F, Holt SK, Koehne EL, Chen JJ, et al
    Patterns of chemotherapy use with primary radiotherapy for localized bladder cancer in patients 65 or older.
    Front Oncol. 2024;14:1341655.
    

    >> Share

    
    

    
    Heliyon

35. ZHANG W, Liang ZQ, He RQ, Huang ZG, et al
    The upregulation and transcriptional regulatory mechanisms of Extra spindle pole bodies like 1 in bladder cancer: An immunohistochemistry and high-throughput screening Evaluation.
    Heliyon. 2024;10:e31192.
    

    >> Share

    
    
36. QIU D, Zhao B, Wang W, Zheng G, et al
    The predictive value of PFKFB3 in bladder cancer prognosis.
    Heliyon. 2024;10:e31347.
    

    >> Share

    
    
37. CHATTERJEE D, Heeamoni SA, Sultana T, Mou SI, et al
    Delineating the mechanistic relevance of the TP53 gene and its mutational impact on gene expression and patients' survival in bladder cancer.
    Heliyon. 2024;10:e31286.
    

    >> Share

    
    

    
    Int J Mol Sci

38. LIN YH, Chen TM, Tsai YL, Tsai WC, et al
    The Reduction of PSMB4 in T24 and J82 Bladder Cancer Cells Inhibits the Angiogenesis and Migration of Endothelial Cells.
    Int J Mol Sci. 2024;25:5559.
    

    >> Share

    
    

    
    Int J Urol

39. MITSUI Y, Okawa M, Hori S, Uetani M, et al
    Effectiveness of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin as compared to gemcitabine-based regimens as neoadjuvant chemotherapy for oncologic outcomes in muscle-invasive bladder cancer cases-Single-center study in Japan.
    Int J Urol. 2024 May 31. doi: 10.1111/iju.15509.
    

    >> Share

    
    

    
    Ir J Med Sci

40. RONAN K, Jordan E, Leonard C, McDermott R, et al
    Frequency of next-generation sequencing, prevalence of targetable mutations and response to targeted therapies amongst patients with metastatic urothelial cancer in Ireland: a multi-centre retrospective study of real-world data.
    Ir J Med Sci. 2024;193:1155-1161.
    

    >> Share

    
    

    
    J Biomed Res

41. WANG P, Wei X, Qu X, Zhu Y, et al
    Potential clinical application of microRNAs in bladder cancer.
    J Biomed Res. 2024 Jan 25:1-18. doi: 10.7555/JBR.37.20230245.
    

    >> Share

    
    

    
    J Cancer

42. WANG T, Wang G, Shan D, Fang Y, et al
    ACAT1 promotes proliferation and metastasis of bladder cancer via AKT/GSK3beta/c-Myc signaling pathway.
    J Cancer. 2024;15:3297-3312.
    

    >> Share

    
    
43. YU X, Li S, Ke S, Ye C, et al
    CSF2 Impairs Nrf2 Signaling through the Akt/Mtor Pathway in the Development of Bladder Cancer.
    J Cancer. 2024;15:3242-3253.
    

    >> Share

    
    

    
    J Clin Neurosci

44. ONDER T, Karacin C, Kekilli E, Goksel F, et al
    Predicting survival after brain metastases in patients with bladder cancer.
    J Clin Neurosci. 2024;125:146-151.
    

    >> Share

    
    

    
    J Immunother

45. LI B, Jin K, Liu Z, Su X, et al
    RAD51 Expression as a Biomarker to Predict Efficacy of Platinum-Based Chemotherapy and PD-L1 Blockade for Muscle-Invasive Bladder Cancer.
    J Immunother. 2024 May 27. doi: 10.1097/CJI.0000000000000525.
    

    >> Share

    
    

    
    J Med Case Rep

46. MIYAZAKI T, Taguchi S, Obata N, Mizobuchi S, et al
    Severe hypotension and postoperative cardiac arrest caused by 5-aminolevulinic acid: a case report.
    J Med Case Rep. 2024;18:264.
    

    >> Share

    
    

    
    JNCI Cancer Spectr

47. NECCHI A, Ramlau R, Falcon Gonzalez A, Chaudhry A, et al
    Derazantinib alone and with atezolizumab in metastatic urothelial carcinoma with activating FGFR aberrations.
    JNCI Cancer Spectr. 2024;8:pkae030.
    

    >> Share

    
    

    
    Kaohsiung J Med Sci

48. YANG FK, Tian C, Zhou LX, Guan TY, et al
    The value of urinary exosomal microRNA-21 in the early diagnosis and prognosis of bladder cancer.
    Kaohsiung J Med Sci. 2024 May 27. doi: 10.1002/kjm2.12845.
    

    >> Share

    
    

    
    Med Image Anal

49. YUE X, Huang X, Xu Z, Chen Y, et al
    Involving logical clinical knowledge into deep neural networks to improve bladder tumor segmentation.
    Med Image Anal. 2024;95:103189.
    

    >> Share

    
    

    
    Mol Biotechnol

50. SHI W, Dong J, Zhong B, Hu X, et al
    Predicting the Prognosis of Bladder Cancer Patients Through Integrated Multi-omics Exploration of Chemotherapy-Related Hypoxia Genes.
    Mol Biotechnol. 2024 May 28. doi: 10.1007/s12033-024-01203.
    

    >> Share

    
    

    
    Mol Cancer Ther

51. SEREMAK JR, Gupta KB, Bonigala S, Liu E, et al
    Targeting Chemoresistance in Advanced Bladder Cancers with a Novel Adjuvant Strategy.
    Mol Cancer Ther. 2024 May 30. doi: 10.1158/1535-7163.MCT-23-0806.
    

    >> Share

    
    

    
    Mol Med Rep

52. LIAO YX, Zeng JM, Zhou JJ, Yang GH, et al
    [Retracted] Silencing of RTKN2 by siRNA suppresses proliferation, and induces G1 arrest and apoptosis in human bladder cancer cells.
    Mol Med Rep. 2024;30:134.
    

    >> Share

    
    

    
    Nat Commun

53. DRESSLER FF, Diedrichs F, Sabtan D, Hinrichs S, et al
    Proteomic analysis of the urothelial cancer landscape.
    Nat Commun. 2024;15:4513.
    

    >> Share

    
    

    
    Nat Prod Res

54. GHANADIAN M, Aghaei M, Akhavan Roofigar A, Ayatollahi SA, et al
    Discovery of new 13(17)-epoxymyrsinane diterpenes from aerial flowering parts of euphorbia spinidens Bornm. ex Prokh. with proapoptotic activities against human bladder cancer EJ138 cells.
    Nat Prod Res. 2024 May 30:1-8. doi: 10.1080/14786419.2024.2358389.
    

    >> Share

    
    

    
    Pathologie (Heidelb)

55. LINDEMANN-DOCTER K, Gaisa NT
    [Mimickers and diagnostic pitfalls of urinary bladder cancer].
    Pathologie (Heidelb). 2024 May 30. doi: 10.1007/s00292-024-01335.
    

    >> Share

    
    

    
    Photodiagnosis Photodyn Ther

56. SUZUKI S, Nagumo Y, Ikeda A, Kojo K, et al
    Patient characteristics correlate with diagnostic performance of photodynamic diagnostic assisted transurethral resection of bladder tumors: A retrospective, single-center study.
    Photodiagnosis Photodyn Ther. 2024;46:104052.
    

    >> Share

    
    
57. NAKAGAWA R, Nohara T, Kano H, Makino T, et al
    Does the quality of endoscopic equipment influence the recurrence rate after photodynamic diagnosis-assisted transurethral resection of bladder tumor?
    Photodiagnosis Photodyn Ther. 2024;46:104023.
    

    >> Share

    
    

    
    Probiotics Antimicrob Proteins

58. CHANG CF, Chang PC, Lee YC, Pan CY, et al
    The Antimicrobial Peptide Tilapia Piscidin 4 Induced the Apoptosis of Bladder Cancer Through ERK/SIRT1/PGC-1alpha Signaling Pathway.
    Probiotics Antimicrob Proteins. 2024 May 28. doi: 10.1007/s12602-024-10296.
    

    >> Share

    
    

    
    Support Care Cancer

59. CALOUDAS AB, Haltom TM, Goltz HH, Badr HJ, et al
    Patient-centered development of a bladder cancer survivorship care plan.
    Support Care Cancer. 2024;32:397.
    

    >> Share

    
    

    
    Technol Cancer Res Treat

60. FAHOUM I, Naamneh R, Silberberg K, Hagege R, et al
    Detection of Muscularis propria Invasion in Urothelial Carcinoma Using Artificial Intelligence.
    Technol Cancer Res Treat. 2024;23:15330338241257479.
    

    >> Share

    
    

    
    Urol Oncol

61. MASSARI M, O'Malley P, Benidir T, Su LM, et al
    Efficacy of BCG for non-muscle invasive bladder cancer following nephroureterectomy for upper tract urothelial carcinoma.
    Urol Oncol. 2024 May 26:S1078-1439(24)00465.
    

    >> Share

    
    
62. ABOU CHAKRA M, McElree IM, Packiam VT, Mott SL, et al
    Early experience with sequential intravesical gemcitabine and docetaxel for micropapillary variant non-muscle invasive bladder cancer.
    Urol Oncol. 2024 May 24:S1078-1439(24)00464.
    

    >> Share

    
    

    
    Urologia

63. SINHA S, Choudhury S, Mishra J, Kundu G, et al
    A study on immunohistochemical expression of HER2/Neu and p63 and its association with grade and invasiveness in case of bladder carcinoma.
    Urologia. 2024;91:284-288.
    

    >> Share

    
    
64. BASIRI A, Zahir M, Soleimani M, Khoshdel AR, et al
    Comparison of different urinary diversions after radical cystectomy in Iran: Assessment of health-related quality of life and financial burden in a Middle Eastern country.
    Urologia. 2024;91:276-283.
    

    >> Share

    
    

    
    World J Urol

65. HEERS H, Gut JM, Hofmann R, Flegar L, et al
    Pilot study for bladder cancer detection with volatile organic compounds using ion mobility spectrometry: a novel urine-based approach.
    World J Urol. 2024;42:353.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share